Drug Shortage Report for APO-DARIFENACIN

Last updated on 2022-01-14 History
Report ID 152758
Drug Identification Number 02452529
Brand name APO-DARIFENACIN
Common or Proper name DARIFENACIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) DARIFENACIN
Strength(s) 15MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100 BTL
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-10
Estimated end date 2022-01-31
Actual end date
Shortage status Actual shortage
Updated date 2022-01-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2022-01-14 French Compare
v1 2022-01-14 English Compare

Showing 1 to 2 of 2